Clinical Management of Olecranon Bursitis: A Review.

J Hand Surg Am · Jun 2021 · Review

Nchinda NN, Wolf JM

Department of Orthopaedic Surgery, University of Chicago, Chicago, IL

Hand & Upper Extremity Shoulder & Elbow

SUMMARY — THE REDUCTIONThis review highlights that nonseptic olecranon bursitis is often self-limited, with recent evidence favoring conservative management over corticosteroid injection or bursectomy.
Abstract, as published

Olecranon bursitis is a disease characterized by inflammation of the olecranon bursa, most often due to microtrauma. Although it is a common condition, there is a lack of evidence-based recommendations for the management of nonseptic olecranon bursitis. The condition is often self-limited and resolves with conservative methods such as rest, ice, compression, orthosis wear, and nonsteroidal anti-inflammatory medications. Older studies have shown resolution of symptoms with intrabursal corticosteroid injections and surgical bursectomy. More recent literature has demonstrated adverse effects of intrabursal injections and surgery compared with noninvasive management for initial treatment of nonseptic olecranon bursitis. In order to better tailor decision-making, it is important that hand surgeons understand the comparative efficacies of each option for management of nonseptic olecranon bursitis.

Featured in the 2026-07-25 issue.

← Primary and secondary stabilizers of the scapholunate joint: …10 Hypotheses in Hand Surgery. →

The Reduction is a free email digest of newly published orthopaedic literature — a handful of new papers in the subspecialties you choose, each summarized like this one. Subscribe free or browse the archive.